Former Congresswoman Backs the Use of Psilocybin in Treating Alcohol Use Disorder

October 6, 2021 12:23:22

Former Congresswoman Mimi Walters (R) has been proclaiming the therapeutic benefits of psychedelic substances. In a recent interview, Walters revealed that somebody close to her family had been struggling to overcome alcohol use disorder while she talked about a legislation that would legalize the possession of various psychedelics.

The former Republican congresswoman, who left Congress in 2019, explained that the close family friend had been able to recover from the disorder with the help of psilocybin after participating in a study conducted at New York University.

Various studies have shown that some psychedelics may be effective in treating conditions such as PTSD, severe depression and addiction. The attention of the media on these studies is among the reasons why Nora Volkow, director of the National Institute on Drug Abuse, believes the United States is seeing an increase in the use of psychedelic substances by young people.

Last year, voters in the state of Oregon approved a measure to legalize psilocybin for therapeutic use. A state panel tasked with giving recommendations on how to implement a legal psilocybin therapy program has authorized a team of researchers to produce a report on the culture, history and science of psilocybin as regulators work towards licensing facilities to administer the psychedelic.

In California, Senator Scott Wiener is sponsoring an initiative that would broadly remove the criminal penalties imposed on the possession of psychedelics, including MDMA, LSD, ibogaine, DMT and psilocybin mushrooms, for individuals aged 21 and above. The measure was approved by two committees of the state assembly as well as the senate before it was pulled by Wiener in order to give it time to garner more support from legislators. The senator plans to reintroduce the measure during next year’s legislative session.

During a psychedelics policy forum held earlier this month, Wiener stated that it took compromise both externally and internally to advance the initiative, noting that the legalization of psychedelic possession was the first step toward decriminalizing all illicit substances and ending the war on drugs.

Psychedelic activists in the state have also filed a petition for the 2022 ballot to make California the first state in the country to legalize magic mushrooms for any and all uses. A fiscal analysis of the measure discovered that doing so would generate local and state tax revenue as well as save California millions in enforcement costs. Advocates have begun to collect signatures, having already been issued with a ballot title and summary by the state attorney general.

Psychedelic-related research has advanced to such an extent that companies such as Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) are studying how compounds such as psilocybin can be vaporized as a medicine.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.